83 FR 14855 - Healthcare Infection Control Practices Advisory Committee (HICPAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 67 (April 6, 2018)

Page Range		14855-14855
FR Document		2018-07050

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. Attendance is limited only by room seating available, (add number of seats that will be available in the room). The public is also welcome to listen to the meeting via teleconference; 100 teleconference lines are available. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt of written public comment is May 3, 2018. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length and delivered in 3 minutes or less. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Written comments received in advance of the meeting will be included in the official record of the meeting. Registration is required to attend in person or on the phone. Interested parties may register at www.cdc.gov/ hicpac.

Federal Register, Volume 83 Issue 67 (Friday, April 6, 2018)

[Federal Register Volume 83, Number 67 (Friday, April 6, 2018)]
[Notices]
[Page 14855]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public; however, visitors must be processed in accordance with 
established federal policies and procedures. Attendance is limited only 
by room seating available, (add number of seats that will be available 
in the room). The public is also welcome to listen to the meeting via 
teleconference; 100 teleconference lines are available. Time will be 
available for public comment. The public is welcome to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed below. The deadline for 
receipt of written public comment is May 3, 2018. All requests must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Members of the public who wish to provide public 
comments should plan to attend the public comment session at the start 
time listed. Please note that the public comment period may end before 
the time indicated, following the last call for comments. Written 
comments received in advance of the meeting will be included in the 
official record of the meeting. Registration is required to attend in 
person or on the phone. Interested parties may register at www.cdc.gov/hicpac.

DATES: The meeting will be held on May 17, 2018, 9:00 a.m. to 5:00 
p.m., EDT, and May 18, 2018, 9:00 a.m. to 12:00 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE, 
Atlanta, Georgia 30329 and teleconference at 866-692-3582, passcode: 
66783078.

FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of 
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, 
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045. Email 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Health and Human Services, regarding (1) the practice of healthcare 
infection prevention and control; (2) strategies for surveillance, 
prevention, and control of infections, antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of CDC guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters To Be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: The 
Healthcare Personnel Guideline Workgroup; the National Healthcare 
Safety Network (NHSN) Workgroup; the Neonatal Intensive Care Unit 
(NICU) Guideline Workgroup; and the Products and Practices Workgroup. 
Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07050 Filed 4-5-18; 8:45 am]
 BILLING CODE 4163-19-P

Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices 14855

the Director, Centers for Disease Control DEPARTMENT OF HEALTH AND CDC, 1600 Clifton Road NE, Mailstop
and Prevention, are authorized under HUMAN SERVICES A–07, Atlanta, Georgia 30329,
Sections 301 and 308 of the Public Telephone (404) 639–4045. Email
Health Service Act to conduct directly Centers for Disease Control and hicpac@cdc.gov.
or by grants or contracts, research, Prevention SUPPLEMENTARY INFORMATION:
experiments, and demonstrations Purpose: The Committee is charged
Healthcare Infection Control Practices with providing advice and guidance to
relating to occupational safety and Advisory Committee (HICPAC)
health and to mine health. The Board of the Director, Division of Healthcare
Scientific Counselors provides guidance AGENCY: Centers for Disease Control and Quality Promotion (DHQP), the Director,
to the Director, National Institute for Prevention (CDC), Department of Health National Center for Emerging and
Occupational Safety and Health on and Human Services (HHS). Zoonotic Infectious Diseases (NCEZID),
research and prevention programs. ACTION: Notice of meeting. the Director, CDC, and the Secretary,
Specifically, the Board provides Health and Human Services, regarding
SUMMARY: In accordance with the (1) the practice of healthcare infection
guidance on the Institute’s research Federal Advisory Committee Act, the prevention and control; (2) strategies for
activities related to developing and CDC announces the following meeting surveillance, prevention, and control of
evaluating hypotheses, systematically for the Healthcare Infection Control infections, antimicrobial resistance, and
documenting findings and Practices Advisory Committee related events in settings where
disseminating results. The Board (HICPAC). This meeting is open to the healthcare is provided; and (3) periodic
evaluates the degree to which the public; however, visitors must be updating of CDC guidelines and other
activities of the National Institute for processed in accordance with policy statements regarding prevention
Occupational Safety and Health: (1) established federal policies and of healthcare-associated infections and
Conform to appropriate scientific procedures. Attendance is limited only healthcare-related conditions.
standards, (2) address current, relevant by room seating available, (add number Matters To Be Considered: The agenda
needs, and (3) produce intended results. of seats that will be available in the will include updates on CDC’s activities
Matters To Be Considered: The agenda room). The public is also welcome to for prevention of healthcare-associated
listen to the meeting via teleconference; infections. It will also include updates
for the meeting addresses occupational
100 teleconference lines are available. from the following HICPAC workgroups:
safety and health issues related to: (1)
Time will be available for public The Healthcare Personnel Guideline
Use of contribution analysis to evaluate
comment. The public is welcome to Workgroup; the National Healthcare
research impact; (2) breach in the submit written comments in advance of Safety Network (NHSN) Workgroup; the
protective barrier system of the glove the meeting. Comments should be Neonatal Intensive Care Unit (NICU)
and gown interface; (3) occupational submitted in writing by email to the Guideline Workgroup; and the Products
safety and health workforce training; contact person listed below. The and Practices Workgroup. Agenda items
and (4) safe-skilled-ready workforce deadline for receipt of written public are subject to change as priorities
update—Research for Young and comment is May 3, 2018. All requests dictate.
Temporary Workers. must contain the name, address, and The Director, Management Analysis
Agenda items are subject to change as organizational affiliation of the speaker, and Services Office, has been delegated
priorities dictate. An agenda is also as well as the topic being addressed. the authority to sign Federal Register
posted on the NIOSH website (http:// Written comments should not exceed notices pertaining to announcements of
www.cdc.gov/niosh/bsc/). Members of one single-spaced typed page in length meetings and other committee
the public who wish to address the and delivered in 3 minutes or less. management activities, for both the
NIOSH BSC are requested to contact the Members of the public who wish to Centers for Disease Control and
Executive Secretary for scheduling provide public comments should plan Prevention and the Agency for Toxic
purposes (see contact information to attend the public comment session at Substances and Disease Registry.
the start time listed. Please note that the
below). Alternatively, written comments Elaine Baker,
public comment period may end before
to the BSC may be submitted via an on- Director, Management Analysis and Services
the time indicated, following the last
line form at the following website: Office, Centers for Disease Control and
call for comments. Written comments Prevention.
http://www.cdc.gov/niosh/bsc/ received in advance of the meeting will
contact.html. Agenda items are subject be included in the official record of the
[FR Doc. 2018–07050 Filed 4–5–18; 8:45 am]
to change as priorities dictate. meeting. Registration is required to BILLING CODE 4163–19–P

The Director, Management Analysis attend in person or on the phone.
and Services Office, has been delegated Interested parties may register at DEPARTMENT OF HEALTH AND
the authority to sign Federal Register www.cdc.gov/hicpac. HUMAN SERVICES
notices pertaining to announcements of DATES: The meeting will be held on May
meetings and other committee 17, 2018, 9:00 a.m. to 5:00 p.m., EDT, Centers for Disease Control and
management activities, for both the and May 18, 2018, 9:00 a.m. to 12:00 Prevention
Centers for Disease Control and p.m., EDT.
Prevention and the Agency for Toxic ADDRESSES: Centers for Disease Control Solicitation of Nominations for
Substances and Disease Registry. and Prevention, Global Communications Appointment to the Advisory
daltland on DSKBBV9HB2PROD with NOTICES

Center, Building 19, Auditorium B, 1600 Committee on Immunization Practices
Elaine Baker, Clifton Road NE, Atlanta, Georgia 30329 (ACIP).
Director, Management Analysis and Services and teleconference at 866–692–3582,
Office, Centers for Disease Control and ACTION: Notice.
passcode: 66783078.
Prevention.
FOR FURTHER INFORMATION CONTACT: Erin SUMMARY: The Centers for Disease
[FR Doc. 2018–07049 Filed 4–5–18; 8:45 am] Stone, M.A., HICPAC, Division of Control and Prevention (CDC) is seeking
BILLING CODE 4163–18–P Healthcare Quality Promotion, NCEZID, nominations for membership on the

VerDate Sep<11>2014 19:21 Apr 05, 2018 Jkt 244001 PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1

Document Created: 2018-11-01 09:15:25
Document Modified: 2018-11-01 09:15:25

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on May 17, 2018, 9:00 a.m. to 5:00 p.m., EDT, and May 18, 2018, 9:00 a.m. to 12:00 p.m., EDT.
Contact		Erin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045. Email [email protected]
FR Citation		83 FR 14855

83 FR 14855 - Healthcare Infection Control Practices Advisory Committee (HICPAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 67 (April 6, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention